Labshake search
Citations for R&D Systems :
551 - 600 of 1389 citations for 4R 5S 2 5 Fluoropyridin 2 yl 4 5 diphenyl 4 5 dihydrooxazole since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... IL-2 (R&D Systems, 202-IL-010) or IL-15 (R&D Systems ...
-
bioRxiv - Physiology 2022Quote: ... with EGM-2 growth factors (R&D Systems), 10% fetal bovine serum (FBS) ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-10 ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-6 (Peprotech) ...
-
bioRxiv - Immunology 2022Quote: ... 50 U/mL IL-2 (R&D Systems), 10 ng/mL IL-15 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 1000 unit/mL IL-2 (R&D systems), anti-CD3 (2ug/mL) ...
-
bioRxiv - Microbiology 2020Quote: ... 30 IU/ml IL-2 (R&D Systems), Glutamax ...
-
bioRxiv - Bioengineering 2022Quote: ... 2 ng/ mL IGF-1 (R&D Systems), and 10 ng/ mL HGF (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... or rmIL-13 (2 μg, R&D systems) in calcium- and magnesium-free phosphate buffered saline (PBS) ...
-
bioRxiv - Developmental Biology 2021Quote: ... and N-2 Plus supplement (R&D Systems) in DMEM/F-12 (Gibco ...
-
Enhancer Remodeling Promotes Tumor-Initiating Activity in NRF2-Activated Non-Small Cell Lung CancersbioRxiv - Cancer Biology 2020Quote: ... N-2 Plus Media Supplement (R&D Systems), Gibco B-27 Supplement (Thermo Fisher Scientific) ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% N21 (R&D Systems, AR008), 1% penicillin/streptomycin (ThermoFisher Scientific ...
-
bioRxiv - Cell Biology 2020Quote: ... and 2 μg/mL EGF (R&D Systems)] at 5×10^4 cells/mL in non-adherent 24-well culture plates (Corning ...
-
bioRxiv - Immunology 2021Quote: ... and mIL-2 (10ng/ml; R&D Systems) for Treg polarization ...
-
bioRxiv - Cell Biology 2021Quote: ... This antibody (clone #P3H9-2; R&D Systems) has been demonstrated to detect antigen in a variety of epithelia and has been shown to inhibit cell proliferation of both rat and human epithelial cells (32) ...
-
bioRxiv - Immunology 2021Quote: ... 17 ng/ml IL-2 (R&D Systems) was added to the cultures ...
-
bioRxiv - Bioengineering 2022Quote: ... 200 IU/ml IL-2 (R&D systems), 120 IU/mL IL-7 (R&D systems) ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant BMP-2 (R&D Systems, Minneapolis, MN) at varying doses (0 ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2 μM Forskolin (R&D system, 1099) for vascular lineage promotion ...
-
bioRxiv - Cell Biology 2022Quote: ... and 2 μM Forskolin (R&D system, 1099). On day 6 ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant IL-2 (R&D Systems MN, Canada), Magnetic beads coated with anti-CD3 and anti-CD28 antibodies (Invitrogen ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 2 (# 3533-010-02 R&D systems), or 2.5 mg/mL OmGel at a concentration of 1000 cells / µL and plated as a droplet in 48-well or 96 well plates ...
-
bioRxiv - Systems Biology 2022Quote: ... IL-2 (R&D Systems, 202-IL-010) or IL-15 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... IL-2 (12 ng/ml; R&D Systems); all-trans retinoic acid (ATRA ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-10 ...
-
bioRxiv - Cancer Biology 2024Quote: ... LY6A (R&D systems, 2 μg/ml, AF1226), APOE (1:200 ...
-
bioRxiv - Molecular Biology 2024Quote: ... Siglec-2 Fc chimera protein (R&D Systems), Siglec-3 Fc chimera protein (R&D Systems) ...
-
bioRxiv - Physiology 2024Quote: ... Contactin-2 1:1000 (R&D Systems AF4439), MLC2v 1:2000 (Proteintech 10906-1-AP) ...
-
bioRxiv - Immunology 2024Quote: ... IL-2 (R&D Systems, 10 IU/mL), IL-7 (R&D Systems ...
-
bioRxiv - Biophysics 2024Quote: ... Type 2 (3533-010-02 R&D systems) and seeded on glass chamber slides in 20 μL domes and cultured in F-12 Ham Nutrient media with 1% penicillin/streptomycin ...
-
bioRxiv - Cancer Biology 2024Quote: ... Type 2 (R&D Systems, 3533-005-02).
-
bioRxiv - Biophysics 2024Quote: ... Type 2 (3533-010-02 R&D systems) and seeding on glass chamber slides in 20 μL domes ...
-
bioRxiv - Microbiology 2022Quote: ... Blots were incubated for 1 hour with HRP-conjugated secondary antibodies diluted in 5% skim milk: anti-mouse (HAF007, R&D Systems, 1:25,000); anti-rabbit (111-035-144 ...
-
bioRxiv - Neuroscience 2020Quote: ... Mice were administered either a 5 μL volume of phosphate-buffered saline (PBS) containing 10 μg/kg of carrier-free rmIL-1β (R&D Systems, Minneapolis, MN) or PBS alone (control ...
-
bioRxiv - Microbiology 2021Quote: ... The medium for differentiation consisted of DMEM/F12 supplemented with 5% R-Spondin1 conditioned medium (home made from Cultrex 293T R-spondin1-expressing cells, R&D Systems, MN, USA), 10% Noggin conditioned medium (home made with HEK293-mNoggin-Fc cells ...
-
bioRxiv - Cell Biology 2021Quote: ... media was replaced with RPMI supplemented with B27 without insulin and containing 1 µM CHIR99021 and 5 ng/ml BMP4 (R&D systems #314-BP). After an additional 48 hours (Day 3) ...
-
bioRxiv - Cell Biology 2020Quote: ... were covered with HUVECs and embedded 24 hours later in a 2,5 mg/mL fibrin gel in the presence or absence of VEGFA-165 at 5 ng/mL (R&D systems, Minneapolis MN, USA). Conditioned media from papillary or reticular fibroblasts were added on top of the gel and renewed every day for four days ...
-
bioRxiv - Pathology 2022Quote: ... blocking-and antibody-incubations were performed in TBS + 0,1% Tween20 + 5% milk. Following primary antibodies (Suppl. Table 1) were used: anti-NRP1 (1:1000, R&D Systems, Cat. No. AF566), anti-NRP2 (1:1000 ...
-
bioRxiv - Neuroscience 2021Quote: ... Filters were blocked in 5% nonfat milk in TBS-Tween 20 (0.1%) and incubated overnight with rabbit anti-NrCAM (R&D Systems AF8538, 1:1000), mouse anti-Rac1 (BD Biosciences # 610651 ...
-
bioRxiv - Molecular Biology 2020Quote: ... cells were washed twice with PBS and stimulated with cytokine cocktail consisting of IL-1β (5 ng/ml, R&D Systems, Minneapolis, MN, USA), and IFN-γ (50 ng/ml ...
-
bioRxiv - Cancer Biology 2020Quote: ... PBS or conditioned media from lung stromal cells from HFD-fed mice treated with 5 μg/mL of either CSF2 neutralizing antibodies (R&D Systems, MAB415-100) or rat IgG antibodies (R&D Systems ...
-
bioRxiv - Microbiology 2021Quote: ... were cultured for 7 days in RPMI supplemented with 5% decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, #216-MC) to obtain MDMs ...
-
bioRxiv - Cell Biology 2022Quote: ... MDA-MB-231 and HEK293T cells (ATCC) were cultured in DMEM (4.5 g/liter glucose, pH 7.2) with 5% FBS (Atlanta Biologicals/R&D Systems #S11150, Lot #F18071) 20 mM Hepes ...
-
bioRxiv - Immunology 2021Quote: ... cells were starved for 5 hours in DermaLife Basal Medium followed by stimulation with human recombinant IL-17A (R&D systems, 50 ng/ml) and TNF-α (R&D systems ...
-
bioRxiv - Physiology 2022Quote: ... and were further stratified to either treatment of 5 d/wk injections of recombinant sclerostin (0.1 mg/kg body mass) (cat# 1589-ST; R&D Systems, Minneapolis, Minnesota, USA) or saline control ...
-
bioRxiv - Neuroscience 2022Quote: ... a mix of 10 μg/mL Laminin and 5 μg/mL of each SLRP protein (recombinant human CHAD (R&D Systems Cat#8218-CH), FMOD (R&D Systems Cat#9840-FM) ...
-
bioRxiv - Bioengineering 2024Quote: ... foregut cells in the 24-well plate or on the pillar plate were cultured in advanced DMEM/F12 supplemented with 5 ng/mL recombinant human FGF basic/FGF2/bFGF (R&D systems; 233-FB), 10 ng/mL recombinant human VEGF-165 (Gibco ...
-
bioRxiv - Physiology 2023Quote: ... 1nM) in VEH for 60 minutes prior to the addition of recombinant human TGF-β1 (5 ng/ml; R&D Systems, Minneapolis, MN, USA). At 6 ...
-
bioRxiv - Genetics 2023Quote: ... with the addition of the TET inhibitor molecule Bobcat 339 (concentration of 5 µM, 10 µM or 30 µM, R&D Systems, 6977/10) or in the absence of ascorbic acid (normally added to the reprogramming medium at 25 mg/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... After transfection neurons were washed twice with NBP and treated with 20 μM (2R)-amino-5-phosphonovaleric acid (AP5; R&D Systems, 0105/10), an NMDA receptor antagonist to prevent transfection-induced neuronal overexcitation ...